Dow Up2.00% Nasdaq Up1.66%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
3.43 Up 0.19(5.71%) Feb 12, 3:59PM EST
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:360.29M
Enterprise Value (Feb 14, 2016)3:258.60M
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2016)1:N/A
PEG Ratio (5 yr expected)1:-0.03
Price/Sales (ttm):40.26
Price/Book (mrq):2.81
Enterprise Value/Revenue (ttm)3:30.55
Enterprise Value/EBITDA (ttm)6:-2.16
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 31
Most Recent Quarter (mrq):Sep 30, 2015
Profitability
Profit Margin (ttm):N/A
Operating Margin (ttm):-1,420.41%
Management Effectiveness
Return on Assets (ttm):-53.39%
Return on Equity (ttm):-114.34%
Income Statement
Revenue (ttm):8.47M
Revenue Per Share (ttm):0.08
Qtrly Revenue Growth (yoy):1,543.80%
Gross Profit (ttm):10.33M
EBITDA (ttm)6:-119.70M
Net Income Avl to Common (ttm):-125.65M
Diluted EPS (ttm):-1.25
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):102.21M
Total Cash Per Share (mrq):0.97
Total Debt (mrq):0.00
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):4.83
Book Value Per Share (mrq):1.15
Cash Flow Statement
Operating Cash Flow (ttm):-136.47M
Levered Free Cash Flow (ttm):-88.06M
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
Beta:3.17
52-Week Change3:-71.20%
S&P500 52-Week Change3:-11.22%
52-Week High (Mar 20, 2015)3:14.89
52-Week Low (Jan 20, 2016)3:2.80
50-Day Moving Average3:3.77
200-Day Moving Average3:4.79
Share Statistics
Avg Vol (3 month)3:1,644,350
Avg Vol (10 day)3:1,249,960
Shares Outstanding5:105.19M
Float:60.70M
% Held by Insiders1:26.59%
% Held by Institutions1:61.50%
Shares Short (as of Jan 29, 2016)3:24.04M
Short Ratio (as of Jan 29, 2016)3:14.86
Short % of Float (as of Jan 29, 2016)3:28.82%
Shares Short (prior month)3:25.04M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Sep 30, 2015)
ttm = Trailing Twelve Months (as of Sep 30, 2015)
yoy = Year Over Year (as of Sep 30, 2015)
lfy = Last Fiscal Year (as of Dec 31, 2014)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.